This manual for clinicians provides guidelines for clinical care of persons with HIV/AIDS. This updated version incorporates many new insights, but the time-tested format has been retained – easy access to crucial facts for a busy clinician. The guide touches on every topic facing people with HIV and their caregivers.
This information kit contains a letter announcing the publication of the report,"Recommendations for Case Management Collaboration and Coordination in Federally Funded HIV/AIDS Programs" and the report. The report describes the use of case management in different settings, examines benefits and barriers to case management collaboration and coordination, and identifies methods for strengthening linkages between HIV/AIDS case management programs. It includes examples of successful models to aid users in eliminating or reducing service gaps and duplication in the delivery of services.
This report provides epidemiological data on persons living with HIV/AIDS to determine funding levels for Ryan White, Parts A and B (formerly Titles I and II). For FY 2009, CDC provided HRSA with data files containing the total number of persons reported living with AIDS through calendar year 2007 for all jurisdictions. In FY 2009, HRSA, for the third year in a row, used total counts of living cases of HIV and living cases of AIDS in the Ryan White HIV/AIDS Treatment Program Parts A and B allocation formulae.
This monograph is a guide developed by the HIV/AIDS Bureau of the US Department of Health and Human Services, Health Resources and Services Administration for clinicians in the diagnosis, evaluation, and treatment of hepatitis C virus as part of primary care for HIV-infected persons. It provides a quick reference in key aspects of HCV care and treatment for HIV-infected patients.
This slide set discusses use of the Ryan White Care Act (RWCA) to provide treatment of hepatitis C coinfection in persons living with HIV. It presents an overview of viral hepatitis, the basics of hepatitis C compared with hepatitis A and B, acute and chronic infection, prevention, HCV treatment and side effects of treatment, treatment decisions,, barriers to treatment, and increasing access to treatment through the RWCA.
This report provides epidemiological data on persons living with HIV/AIDS to determine funding levels for Ryan White, Parts A and B (formerly Titles I and II). In FY2010, HRSA, for the fourth year in a row, used total counts of living cases of HIV and living cases of AIDS in the Ryan White HIV/AIDS Treatment Program Parts A and B allocation formulae. Prior to FY2007, only AIDS cases, adjusted by a survival rate (estimated living AIDS cases), were used in the formulae.
These performance measures, created by the HIV AIDS Bureau (HAB) of the Health Resources and Services Administration (HRSA), are comprised of indicators that providers can use to monitor the quality of care they provide patients with who have HIV/AIDS. The performance measures also include screening for hepatitis B and C and hepatitis B vaccination.